Search

everythinglearnresearchcommunity

for

Search:↓

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Targeting EGFR may help reduce hair loss from chemotherapy.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Vinblastine and its metabolites may cause nausea and hair loss by binding to specific receptors and could lead to better chemotherapy drugs with fewer side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

A topical lotion helped manage hair loss from chemotherapy by affecting cell death, inflammation, and collagen, with no side effects.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

A cancer patient's hair became permanently curly after treatment with nivolumab.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The nanogel with Ciclopirox Olamine is a promising treatment for skin yeast infections.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

The document lists research on Pemetrexed and Cisplatin for lung cancer but doesn't give a final conclusion.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.